Annika Kurreck1, Sebastian Stintzing1, Dominik P Modest1. 1. Annika Kurreck, MD, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Tumor Immunology (CVK), Berlin, Germany; Sebastian Stintzing, MD, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Tumor Immunology (CCM), Berlin, Germany; and Dominik P. Modest, MD, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Tumor Immunology (CVK), Berlin, Germany.